Skip to content
ELIOS logo in Paris timeline

Elios Vision announces registration of ELIOS in France

ELIOS is now registered for use in France. ELIOS is an innovative technology used to treat glaucoma at the same time as cataract surgery. It does not require an implant and provides long-lasting results that may free patients and their doctors from the demands of drop therapy.1 ELIOS technology uses excimer laser energy to create microscopic openings in the trabecular meshwork (TM) to re-establish the natural flow of aqueous.

“The ELIOS procedure is filling the gap for patients who don’t need an aggressive surgical approach, but are not doing well with drop therapy or would be much better off reducing their drop regimen,” says Ike Ahmed, MD, a Canada-based ophthalmologist and world-renowned glaucoma expert. “ELIOS has been particularly impactful for cataract surgery in my practice. It just makes sense to combine ELIOS with cataract surgery when you’re already going into the eye.”

As the leading cause of blindness worldwide, glaucoma is a devastating disease. ELIOS provides an opportunity to address the most common cause of blindness during the most commonly performed surgical procedure in the world with a safety profile similar to cataract surgery.2

“Multiple clinical studies across Europe have demonstrated that ELIOS has a strong efficacy and safety profile, with significant advantages over other forms of microinvasive glaucoma surgery (MIGS),” said Elliot Friedman, Chief Executive Officer of Elios Vision.

One such advantage ELIOS technology has over other forms of MIGS is that it is implant free, meaning fewer decisions for surgeons and less potential post-op trauma for patients. Furthermore, ELIOS’ use of an excimer laser lowers the surgery’s complexity, both intra- and post-op, as it avoids thermal or mechanical trauma.1 The ten microchannels this technology creates have proven to be effective and long-lasting for up to eight years.2

“The ELIOS technology appears to be a promising technology for lowering IOP and medication use in patients with glaucoma and has been used in other EU countries for several years. The fact that ELIOS uses a laser to enhance outflow is appealing as this makes the procedure less traumatic than conventional methods and avoids the use of implants,” says Prof Philippe Denis, Glaucoma Specialist, Hôpital de la Croix-Rousse, Lyon, France.

Elios Vision was founded in partnership with MLase, a world leader in excimer laser technology and now has a team dedicated to driving forward the global clinical and regulatory strategy for the novel excimer laser platform and procedure.

Matt Coleman

  1. Töteberg-Harms et al. BMC Ophthalmology 2013
  2. Riesen M, Funk J, Töteberg-Harms M. “Long-term treatment success and safety of combined phacoemulsification plus excimer laser trabeculostomy: an 8-year follow-up study”. Graefes Arch Clin Exp Ophthalmol. 2022 Jan 16.

Share This Story

Latest News

Elios Vision announces collaboration with the International Glaucoma Surgical Registry

Elios Vision will be collaborating with the ISGR, an open-access tool which enables surgeons to compare outcomes with other centres.
Elios Vision logo

Elios Vision achieves three new pipeline milestones

Elios announced enrollment completion in their U.S. pivotal trial, the expansion of the U.S. pre-launch team, and continued commercial uptake in Europe.
The Ophthalmologist logo

The ELegance of ELIOS

Learn why Dusseldorf-based surgeon Karsten Klabe prefers the ELIOS procedure when treating patients for open-angle glaucoma.

Join Our Email List

Stay up-to-date on the next generation of glaucoma treatment. Subscribe to receive educational and promotional information from Elios Vision.

Email Signup

Site for Healthcare Professionals Only

You are about to access Elios Vision’s online platform for healthcare professionals outside of the United States. This platform is intended to provide general product information for education and illustration purposes. It is not intended to provide information to the general public or medical advice.

As product information, availability, indication, and trade names may vary from country to country, the content of this site may not be fully in-line with the approved or cleared product information in the country you are accessing from. Unless stated otherwise for specific product or event pages, the content on this site is based on the regulatory and legal principles applicable to the United Kingdom.

By clicking “Proceed,” I confirm that:

  • I understand that this platform is directed to Healthcare Professionals only and that I am a licensed Healthcare Professional.
  • I have read and agree to Elios Vision’s terms and conditions and privacy policy.